CSPC Pharmaceutical Group (HK:1093) has released an update.
CSPC Pharmaceutical Group Limited has announced the purchase of 7 million shares under its restricted share award scheme for approximately HK$47.44 million, representing about 0.059% of the total shares issued. These shares were bought at an average price of HK$6.777 each and will be held in trust for selected participants of the scheme. The company’s board will continue to assess and determine the appropriate number of shares to be awarded and purchased in the future.
For further insights into HK:1093 stock, check out TipRanks’ Stock Analysis page.
